Trials that use: Covariate adjustment
5,848 results
- Percutaneous RVAD to Preemptively Treat Right Heart Failure Post-LVAD: Complete Statistical AnalysisIndependent statistical analysis of Percutaneous RVAD to Preemptively Treat Right Heart Failure Post-LVAD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04458103).
- Perfluorohexyloctane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease (DED): Complete Statistical AnalysisIndependent statistical analysis of Perfluorohexyloctane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease (DED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PERFORMIndependent statistical analysis of Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma: primary endpoint results, effect estimate with confidence interval,…
- Performance and Acceptance of Optive Versus Hylocomod Eyedrops in Patients With Dry Eye Symptoms: Complete Statistical AnalysisIndependent statistical analysis of Performance and Acceptance of Optive Versus Hylocomod Eyedrops in Patients With Dry Eye Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Performance Evaluation of Different Daily Disposable Silicone Hydrogel Contact Lenses: Complete Statistical AnalysisIndependent statistical analysis of Performance Evaluation of Different Daily Disposable Silicone Hydrogel Contact Lenses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05805059).
- Performance Evaluation of the AMIA APD Solution Generation System in Patients End Stage Renal Disease (ESRD): Complete Statistical AnalysisIndependent statistical analysis of Performance Evaluation of the AMIA APD Solution Generation System in Patients End Stage Renal Disease (ESRD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Performance of Two Toric Silicone Hydrogel Contact Lenses: Complete Statistical AnalysisIndependent statistical analysis of Performance of Two Toric Silicone Hydrogel Contact Lenses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03578926).
- Peri-implantitis Treatment: Clinical Results of Conventional Treatment vs. the Addition of Biolase: Complete Statistical AnalysisIndependent statistical analysis of Peri-implantitis Treatment: Clinical Results of Conventional Treatment vs. the Addition of Biolase: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Perioperative Use of Gabapentin To Decrease Narcotic Requirements in Spinal Fusion: Complete Statistical AnalysisIndependent statistical analysis of Perioperative Use of Gabapentin To Decrease Narcotic Requirements in Spinal Fusion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Peripheral Dopamine in Postural Tachycardia Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Peripheral Dopamine in Postural Tachycardia Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00685919).
- Peripheral Nerve Ultrasound for Diagnosis and Prognosis of Guillain-Barre Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Peripheral Nerve Ultrasound for Diagnosis and Prognosis of Guillain-Barre Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04053452).
- Peritoneal Dialysis vs Furosemide for Acute Kidney Injury After Cardiopulmonary Bypass: Complete Statistical AnalysisIndependent statistical analysis of Peritoneal Dialysis vs Furosemide for Acute Kidney Injury After Cardiopulmonary Bypass: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PERSISTIndependent statistical analysis of Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01358357).
- PersistIndependent statistical analysis of Psychosocial Pain Management to Improve Opioid Use Disorder Treatment Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04433975).
- PERSIST-AVRIndependent statistical analysis of Perceval Sutureless Implant Versus Standard-Aortic Valve Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02673697).
- Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib Vaccines: Complete Statistical AnalysisIndependent statistical analysis of Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib Vaccines: primary endpoint results, effect estimate with confidence interval, sample-size…
- Persistence of Protection by Shingrix: Complete Statistical AnalysisIndependent statistical analysis of Persistence of Protection by Shingrix: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04169009).
- Personalized Feedback for Distress Intolerant Smokers: Complete Statistical AnalysisIndependent statistical analysis of Personalized Feedback for Distress Intolerant Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03918031).
- Personalized Therapeutic Neuromodulation for Anhedonic Depression: Complete Statistical AnalysisIndependent statistical analysis of Personalized Therapeutic Neuromodulation for Anhedonic Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05144789).
- PET Imaging of the Dopaminergic and Serotonergic Systems in Treated HIV Positive Subjects: Complete Statistical AnalysisIndependent statistical analysis of PET Imaging of the Dopaminergic and Serotonergic Systems in Treated HIV Positive Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PET-CRAIndependent statistical analysis of Imaging the Neurobiology of a Behavioral Treatment for Cocaine Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00376558).
- PET-MR for Prediction and Monitoring of Response to Neoadjuvant Chemotherapy in Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of PET-MR for Prediction and Monitoring of Response to Neoadjuvant Chemotherapy in Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PEVARIndependent statistical analysis of Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01070069).
- PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03685591).
- PFAS Exposure and Immune Response to Vaccination in Adults: Complete Statistical AnalysisIndependent statistical analysis of PFAS Exposure and Immune Response to Vaccination in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06588530).
- Ph II Adjuvant Carboplatin/Docetaxel in Curatively Resected Stage I-IIIA NSCLC: Complete Statistical AnalysisIndependent statistical analysis of Ph II Adjuvant Carboplatin/Docetaxel in Curatively Resected Stage I-IIIA NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00280735).
- Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme: Complete Statistical AnalysisIndependent statistical analysis of Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Pharmacist Intervention to Improve Smoking Cessation: Complete Statistical AnalysisIndependent statistical analysis of Pharmacist Intervention to Improve Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06943287).
- Pharmacist Intervention to Reduce Post-Hospitalization Utilization: Complete Statistical AnalysisIndependent statistical analysis of Pharmacist Intervention to Reduce Post-Hospitalization Utilization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04071951).
- Pharmacodynamic Biomarkers to Support Biosimilar Development: PCSK9 Inhibitors: Complete Statistical AnalysisIndependent statistical analysis of Pharmacodynamic Biomarkers to Support Biosimilar Development: PCSK9 Inhibitors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04189484).
- Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia: Complete Statistical AnalysisIndependent statistical analysis of Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.: Complete Statistical AnalysisIndependent statistical analysis of Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Pharmacoeconomic Study Assessing the Cost of Chronic Hepatitis C Treatment With Peginterferon Alfa-2b (PegIntron) and Ribavirin (Rebetol) in the Czech Republic (Study P04588)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of Pharmacoeconomic Study Assessing the Cost of Chronic Hepatitis C Treatment With Peginterferon Alfa-2b (PegIntron) and Ribavirin (Rebetol) in the Czech Republic (Study P04588)(COMPLETED): primary endpoint results, effect estimate…
- Pharmacogenetic Treatment With Anti-Glutaminergic Agents for Comorbid PTSD & AUD: Complete Statistical AnalysisIndependent statistical analysis of Pharmacogenetic Treatment With Anti-Glutaminergic Agents for Comorbid PTSD & AUD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02884908).
- Pharmacogenetics of Alcohol: Treatment Implications: Complete Statistical AnalysisIndependent statistical analysis of Pharmacogenetics of Alcohol: Treatment Implications: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00734656).
- Pharmacogenetics of Nicotine Addiction Treatment: Complete Statistical AnalysisIndependent statistical analysis of Pharmacogenetics of Nicotine Addiction Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01314001).
- Pharmacogenomics of the Variability in the In Vivo Response to Glucocorticoids: Complete Statistical AnalysisIndependent statistical analysis of Pharmacogenomics of the Variability in the In Vivo Response to Glucocorticoids: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Pharmacokinetic Alterations During ECMO: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Alterations During ECMO: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01938079).
- Pharmacokinetic and Exploratory Electrocardiogram (ECG) Study: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic and Exploratory Electrocardiogram (ECG) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01018420).
- Pharmacokinetic and Subjective Effects of Heated Tobacco Products: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic and Subjective Effects of Heated Tobacco Products: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06356610).
- Pharmacokinetic Comparability of Benralizumab Using Accessorized Pre-Filled Syringe or Autoinjector in Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Comparability of Benralizumab Using Accessorized Pre-Filled Syringe or Autoinjector in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pharmacokinetic Study Comparing MB02 And US And EU Avastin® In Healthy Male Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study Comparing MB02 And US And EU Avastin® In Healthy Male Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pharmacokinetic Study of 4 mg Nicotine Lozenge.: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study of 4 mg Nicotine Lozenge.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01669122).
- Pharmacokinetic Study of Cabotegravir and Rilpivirine Long-acting Intramuscular Injections in Healthy Adult Participants: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study of Cabotegravir and Rilpivirine Long-acting Intramuscular Injections in Healthy Adult Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pharmacokinetic Study of Intranasal Dexmedetomidine in Pediatric Patients With Congenital Heart Disease: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study of Intranasal Dexmedetomidine in Pediatric Patients With Congenital Heart Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01401010).
- Pharmacokinetics and Safety of Double-dose Dolutegravir When Used With Rifapentine for HIV-associated Tuberculosis: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Safety of Double-dose Dolutegravir When Used With Rifapentine for HIV-associated Tuberculosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…